Synthesis and antimicrobial evaluation of coumarin-based benzotriazoles and their synergistic effects with chloromycin and fluconazole

Yaoxue Xuebao

Volumn 46, Issue 7, 2011, Pages 798-810

  Shi, Yuan ^a   Zhou, Cheng He ^a   Zhou, Xiang Dong ^b   Geng, Rong Xia ^a   Ji, Qing Gang ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antibacterial; Antifungal; Benzotriazole; Chloromycin; Coumarin; Fluconazole; Synergistic effect

Indexed keywords

ANTIINFECTIVE AGENT; BENZOTRIAZOLE DERIVATIVE; CHLOROMYCIN; COUMARIN DERIVATIVE; FLUCONAZOLE; UNCLASSIFIED DRUG;

ALKYLATION; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOASSAY; CONTROLLED STUDY; CYCLIZATION; DILUTION; DRUG EFFICACY; ETHERIFICATION; FUNGAL STRAIN; FUNGUS GROWTH; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; IN VITRO STUDY; INFRARED SPECTROMETRY; MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROCOCCUS LUTEUS; NONHUMAN; PROTEUS VULGARIS; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CHLORAMPHENICOL; COUMARINS; DRUG SYNERGISM; FLUCONAZOLE; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS; TRIAZOLES;

EID: 80052640394     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Abraham K, Wöhrlin F, Lindtner O, et al. Toxicology and risk assessment of coumarin: focus on human data [J]. Mol Nutr Food Res, 2010, 54: 228-239.
2. Wagner BD. The use of coumarins as environmentally-sensitive fluorescent probes of heterogeneous inclusion systems [J]. Molecules, 2009, 14: 210-237.
3. Dong B, Ma T, Zhang T, et al. Anti-HIV-1 activity and structure-activity relationship of pyranocoumarin analogs [J]. Acta Pharm Sin, 2011, 46: 35-38.
4. Borges F, Roleira F, Milhazes N, et al. Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity [J]. Curr Med Chem, 2005, 12: 887-916. (Pubitemid 40443846)
5. Yuan Y, Zhou CH, Liu Q, et al. New synthetic antibacterial agents [J]. Chin J New Drugs, 2007, 16: 343-350.
6. Wang Y, Zhou CH. Recent advances in the researches of triazole compounds as medicinal drugs [J]. Sci Sin B, 2011, 41 (in press).
7. Mi JL, Zhou CH, Bai X. Advances in triazole antimicrobial agents [J]. Chin J Antibiot, 2007, 32: 587-593. (Pubitemid 350247455)
8. Zhou CH, Zhang FF, Gan LL, et al. Review on supermolecules as chemical drugs [J]. Sci Sin B, 2009, 39: 208-252.
9. Zhou CH, Gan LL, Zhang YY, et al. Review on supermolecules as chemical drugs [J]. Sci China B: Chem, 2009, 52: 415-458.
10. Weite T, Pletz MW. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options [J]. Int J Antimicrob Agents, 2010, 36: 391-400.
11. Zhu CX, Gao PH, Jiang YY. Advances in the study of Candida albicans gene mutation on azole drug resistance [J]. Acta Pharm Sin, 2010, 45: 821-826.
12. Mitscher LA. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents [J]. Chem Rev, 2005, 105: 559-592. (Pubitemid 40351634)
13. Drlica K, Hiasa H, Kerns R, et al. Quinolones: action and resistance updated [J]. Curr Top Med Chem, 2009, 9: 981-998.
14. Hamdi N, Saoud M, Romerosa A, et al. Synthesis, spectroscopic and antibacterial investigations of new hydroxy ethers and heterocyclic coumarin derivatives [J]. J Heterocycl Chem, 2008, 45: 1835-1842.
15. Ronad PM, Noolvi MN, Sapkal S, et al. Synthesis and antimicrobial activity of 7-(2-substituted phenylthiazolidinyl)-benzopyran-2-one derivatives [J]. Eur J Med Chem, 2010, 45: 85-89.
16. Ajani OO, Nwinyi OC. Microwave-assisted synthesis and evaluation of antimicrobial activity of 3-{3-(5-aryl and S-heteroaromatic)acryloyl}-2H- chromen-2-one derivatives [J]. J Heterocycl Chem, 2010, 47: 179-187.
17. Keri RS, Hosamani KM, Reddy HS, et al. Synthesis, in-vitro antimicrobial and cytotoxic studies of novel azetidinone derivatives [J]. Arch Pharm, 2010, 343: 237-247.
18. Manojkumar P, Ravi TK, Gopalakrishnan S. Antioxidant and antibacterial studies of arylazopyrazoles and arylhydrazonopyrazolones containing coumarin moiety [J]. Eur J Med Chem, 2009, 44: 4690-4694.
19. Raghu M, Nagaraj A, Reddy CS. Synthesis and in vitro study of novel bis-[3-(2-arylmethylidenimino-1, 3-thiazol-4-yl)-4-hydroxyl-2H-chromen-2-one-6- yl] methane and bis-[3-(2-arylidenhydrazo-1, 3-thiazol-4-yl)-4-hydroxy-2H- chromen-2-one-6-yl] methane as potential antimicrobial agents [J]. J Heterocycl Chem, 2009, 46: 261-267.
20. Fu J, Yang Y, Zhang XW, et al. Discovery of 1H-benzo[d] [1, 2, 3]triazol-1-yl 3, 4, 5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase [J]. Bioorg Med Chem, 2010, 18: 8457-8462.
21. Hergert LY, Nieto MJ, Becerra MC, et al. Synthesis of N-benzenesulfonylbenzotriazole derivatives, and evaluation of their antimicrobial activity [J]. Lett Drug Des Discov, 2008, 5: 313-318. (Pubitemid 351988713)
22. Wan J, Yan X, Ma CP, et al. Synthesis, structure characterization, and biological evaluation of some new 1, 2, 3-benzotriazole derivatives [J]. Med Chem Res, 2010, 19: 970-983.
23. Patel PD, Patel MR, Kocsis B, et al. Design, synthesis and determination of antifungal activity of 5(6)-substituted benzotriazoles [J]. Eur J Med Chem, 2010, 45: 2214-2222.
24. Wang XL, Wan K, Zhou CH. Synthesis of novel sulfanilamide-derived 1, 2, 3-triazoles and their evaluation for antibacterial and antifungal activities [J]. Eur J Med Chem, 2010, 45: 4631-4639.
25. Wan K, Zhou CH. Synthesis of novel halobenzyloxy and alkoxy 1, 2, 4-triazoles and evaluation for their antifungal and antibacterial activities [J]. Bull Korean Chem Soc, 2010, 31: 2003-2010.
26. Fang B, Zhou CH, Rao XC. Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents [J]. Eur J Med Chem, 2010, 45: 4388-4398.
27. Zhou CH, Fang B, Gan LL. Benzyl chloride tertiary amine double azole antimicrobial compounds, preparation and medical use thereof: CN, 101323594 [P]. 2008-12-17.
28. Zhou CH, Luo Y. Triadimefon and triadimenol compounds having antimicrobial activity, salts, synthetic methods and uses thereof: CN, 101323600 [P]. 2010-08-25.
29. Zhou CH, Mi JL, Wu J, et al. Triazole onium compound with antimicrobial activity, preparation method and medical use: CN, 101391985 [P]. 2009-03-25.
30. Zhou CH, Mi JL. Fluorine triazole ethers derivates and salt with antimicrobial activity, preparation method and medical use: CN, 101391986 [P]. 2009-03-25.
31. Zhou CH, Yu KG, Meng JP, et al. Dibenzimidazole and onium compound thereof, preparation method and medical use thereof: CN, 101397276 [P]. 2009-04-01.
32. Zhou CH, Wu J, Jin L, et al. Triazoles compounds with antimicrobial activity and preparation method and pharmaceutical use thereof: CN, 101445488 [P]. 2009-06-03.
33. Zhou CH, Shi Y. Coumarin azole compounds having antimicrobial activity, synthetic methods and medical use thereof: CN, 200910191097.8 [P]. 2009-10-10.
34. Shi Y, Zhou CH. Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents [J]. Bioorg Med Chem Lett, 2011, 21: 956-960.
35. Zhang FF, Gan LL, Zhou CH. Synthesis, antibacterial and antifungal activities of some carbazole derivatives [J]. Bioorg Med Chem Lett, 2010, 20: 1881-1884.
36. Luo Y, Lu YH, Gan LL, et al. Synthesis, antibacterial and antifungal activities of novel 1, 2, 4-triazolium derivatives [J]. Arch Pharm, 2009, 342: 386-393.
37. Rosato A, Piarulli M, Corbo F, et al. In vitro synergistic action of certain combinations of gentamicin and essential oils [J]. Curr Med Chem, 2010, 17: 3289-3295.
38. Demchok JP, Meletiadis J, Roilides E, et al. Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B against Aspergillus spp [J]. Mycoses, 2010, 3: 239-245.
39. Riveiro ME, Moglioni A, Ramiro Vazquez R, et al. Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells [J]. Bioorg Med Chem, 2008, 16: 2665-2675. (Pubitemid 351380918)
40. Dilek M, Kezer F. Synthesis of poly(aryl ether) dendritic structures based on calix[4]arenes [J]. J Macromol Sci Pure Appl Chem, 2009, 46: 591-596.
41. Katritzky AR, Rachwal S. Synthesis of heterocycles mediated by benzotriazole. 1. Monocyclic systems [J]. Chem Rev, 2010, 110: 1564-1610.
42. Jin L, Zhou CH. 4-[3-(2H-Benzotriazol-2-yl)propoxy]-3-methoxybenzaldehyde [J]. Acta Crystallogr E, 2010, E66: 01264-U168.
43. Jin L. Design, Synthesis and Biological Activities of Novel Chalcone-based Azoles and Their Quantitative Structure-activity Relationship (QSAR) Study, [D]. Chongqing: Southwest University, 2010.
44. Nag OK, Nayak RR, Lim CS, et al. Two-photon absorption properties of cationic 1, 4-bis(styryl)benzene derivative and its inclusion complexes with cyclodextrins [J]. J Phys Chem B, 2010, 114: 9684-9690.
45. Kitahara T, Aoyama Y, Hirakata Y, et al. In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) [J]. Int J Antimicrob Agents, 2006, 27: 51-57. (Pubitemid 43042423)